Tags |
|
|
Digg It - Comment Option for Online Article Submission Sites Discussed
Should online article submission and Ezine content websites have sections
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
for comments from readers of articles like Amazon.com does? Well, it just
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
o happens that many of the top online article submission Internet content
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
website providers do indeed have sections to rate and or comment on the ar
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
icles that the reader reads. Many online article writers like this and som
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
e authors do not and often there are mean spirited folks who post negative
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
comments for really no reason at all or maybe they are a commercial compet
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
itor of the author and the article itself is indeed industry related to th
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
writer’s work.
Personally I do not like the comments and yes I am an onl
Personally I do not like the comments and yes I am an onl
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ine article writer; although most of my comments are fairly nice ones. I d
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
not wish to hear from anyone on the subjects I have written. You see I ei
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ther have a strong opinion or I am so knowledgeable in a subject, I do not
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
want to hear from those who speak before they understand. I also do not li
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ke the “star” system, as often someone will rate an article due to their p
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
litical beliefs, religious beliefs or grading me for grammar. You see, thi
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s is just silly human petty crap. I want the whole thing turned off really
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
on my articles.
Online article submission sites should be careful not to
Online article submission sites should be careful not to
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
alienate their writers and should be weary that competitors might post neg
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
tive or derogatory comments and thus comments on online article content si
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
tes will need to be monitored to keep the peace. Consider all this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/63377/diggit-Comment-Option-for-Online-Article-Submission-Sites-Discussed.html">Comment Option for Online Article Submission Sites Discussed</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/63377/diggit-Comment-Option-for-Online-Article-Submission-Sites-Discussed.html]Comment Option for Online Article Submission Sites Discussed[/url]
Related Articles:
Are you Cut out to Be an Entrepreneur?
Bookmark it:
|